First Trust Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
First Trust Capital Management's TDAC Position: Q2 2026 in Review
First Trust Capital Management sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 299,998 shares — an estimated $3.17M sold.
First Trust Capital Management first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $6.82M in Q4 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.
- First Trust Capital Management reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
- First Trust Capital Management sold 299,998 Translational Development Acquisition Corp shares in Q2 2026, an estimated $3.17M.
- First Trust Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
- First Trust Capital Management's Translational Development Acquisition Corp position peaked at $6.82M in Q4 2025.
- 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.
Based on First Trust Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.